Tower Research Capital LLC (Trc) Autolus Therapeutics PLC Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,940 shares of AUTL stock, worth $8,790. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,940

Previous 13,337 77.96%

Holding current value

$8,790

Previous $46,000 78.26%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.38 - $4.69 $35,141 - $48,761	-10,397 Reduced 77.96%	2,940 $10,000
Q2 2024 Aug 13, 2024	BUY	$3.33 - $5.68 $39,030 - $66,575	11,721 Added 725.31%	13,337 $46,000
Q1 2024 May 15, 2024	SELL	$5.39 - $7.29 $44,074 - $59,610	-8,177 Reduced 83.5%	1,616 $10,000
Q4 2023 Feb 13, 2024	SELL	$2.13 - $6.63 $16,833 - $52,396	-7,903 Reduced 44.66%	9,793 $63,000
Q3 2023 Nov 14, 2023	SELL	$2.32 - $3.36 $17,817 - $25,804	-7,680 Reduced 30.26%	17,696 $41,000
Q2 2023 Aug 14, 2023	SELL	$1.64 - $3.21 $7,137 - $13,969	-4,352 Reduced 14.64%	25,376 $60,000
Q1 2023 May 09, 2023	BUY	$1.75 - $2.25 $18,555 - $23,856	10,603 Added 55.44%	29,728 $55,000
Q4 2022 Feb 10, 2023	BUY	$1.74 - $3.27 $21,955 - $41,260	12,618 Added 193.91%	19,125 $36,000
Q3 2022 Nov 10, 2022	BUY	$2.04 - $3.76 $6,228 - $11,479	3,053 Added 88.39%	6,507 $14,000
Q2 2022 Aug 15, 2022	BUY	$2.04 - $4.68 $979 - $2,246	480 Added 16.14%	3,454 $10,000
Q1 2022 May 12, 2022	SELL	$3.52 - $5.46 $5,019 - $7,785	-1,426 Reduced 32.41%	2,974 $13,000
Q4 2021 Feb 14, 2022	SELL	$5.1 - $7.0 $8,404 - $11,536	-1,648 Reduced 27.25%	4,400 $23,000
Q3 2021 Nov 15, 2021	BUY	$5.32 - $7.37 $18,417 - $25,514	3,462 Added 133.87%	6,048 $40,000
Q2 2021 Aug 16, 2021	SELL	$4.78 - $7.96 $2,361 - $3,932	-494 Reduced 16.04%	2,586 $17,000
Q1 2021 May 17, 2021	BUY	$5.49 - $9.36 $8,059 - $13,740	1,468 Added 91.07%	3,080 $17,000
Q4 2020 Feb 16, 2021	SELL	$8.13 - $12.79 $29,194 - $45,928	-3,591 Reduced 69.02%	1,612 $14,000
Q3 2020 Nov 16, 2020	BUY	$11.64 - $16.3 $50,203 - $70,301	4,313 Added 484.61%	5,203 $61,000
Q2 2020 Aug 13, 2020	BUY	$5.38 - $16.14 $1,393 - $4,180	259 Added 41.05%	890 $14,000
Q1 2020 May 15, 2020	SELL	$4.2 - $13.0 $6,703 - $20,748	-1,596 Reduced 71.67%	631 $4,000
Q4 2019 Feb 07, 2020	BUY	$11.13 - $16.28 $24,786 - $36,255	2,227 New	2,227 $29,000
Q2 2019 Aug 13, 2019	SELL	$15.1 - $31.25 $45,919 - $95,031	-3,041 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$24.38 - $34.71 $74,139 - $105,553	3,041 New	3,041 $96,000
Q4 2018 Feb 14, 2019	SELL	$24.21 - $48.01 $1,646 - $3,264	-68 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$20.86 - $33.33 $1,418 - $2,266	68 New	68 $2,000

Others Institutions Holding AUTL

# of Institutions

104

Shares Held

163M

Call Options Held

2.8K

Put Options Held

13.4K

View Full List

About Autolus Therapeutics plc

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $272M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

More about AUTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Autolus Therapeutics PLC Transaction History